Table 1.
Results of the HR-HPV testing and cytology for cervical disease
| Total | CIN2+ | CIN3+ | Cancer | |
|---|---|---|---|---|
| Number | 10,183 | 276 | 197 | 70 |
| HR-HPV (+) | 1677 | 252 | 180 | 68 |
| % of number; 95% CIa | 16.49; 15.75–17.20 | 91.30; 87.34–94.35 | 91.37; 86.54–94.89 | 97.14; 90.06–99.65 |
| Cytology ≥ASC-US | 970 | 243 | 177 | 66 |
| % of number; 95% CI | 9.52; 8.96–10.11 | 88.04; 83.62–91.63 | 89.85; 84.76–93.69 | 94.29; 86.01–98.42 |
Note:
a
The CI calculation was based on the exact CI for that proportion.
Abbreviations: CIN, cervical intraepithelial neoplasia; HR-HPV, high-risk human papillomavirus; ASC-US, atypical squamous cells of undetermined significance.